Related Experiment Video
Updated: Aug 15, 2026

The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
[Withdrawal syndrome after the use of serotonin reuptake inhibitors]
1Kommunelegekontoret i Froland.
Background:
The use of serotonin reuptake inhibitors in the treatment of depression has increased significantly over the years since their introduction in Norway in the early 1990s. Reports of side effects have paralleled the increased use; one side effect is the withdrawal syndrome associated with serotonin reuptake inhibitors.
Material And Methods:
This article reports on two patients who discontinued paroxetine and experienced unusual shock-like symptoms consistent with this syndrome.
Results:
There are numerous reports documenting withdrawal reactions caused by these antidepressants. Recently the first controlled studies have been published.
Interpretation:
This syndrome is not well known and differs from the withdrawal syndrome caused by tricyclic antidepressants.
More Related Videos
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
G-protein Coupled Receptors
Drugs Affecting Neurotransmitter Release or Uptake
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists